SUMMARY

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin ), hydrocodone (Vicodin ), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
This report mainly analyzes the market size of Opioids Drug industry, supply & demand of Opioids Drug market, competition of Opioids Drug market and operation of main companies, and makes a scientific forecast for the future development of Opioids Drug industry. According to 99Strategy, the global Opioids Drug market is estimated to grow at an estimated CAGR of xx% in the next 5 years and reach xxx million USD in 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Opioids Drug by different type, application and regions, in addition, this report introduces market competition situation among the companies and company profile, besides, market price analysis and value chain features are covered in this report.
On the basis of Opioids Drug industry research, combined with the development status of global and Chinese Opioids Drug industry market, this report has carried out a comprehensive and detailed research on all kinds of Opioids Drug market information through senior research team, and relying on authoritative data resources and long-term market monitoring database. This report can help investors accurately grasp the current market situation of Opioids Drug industry, predict the future of Opioids Drug industry, excavate the investment value of Opioids Drug industry, and put forward suggestions on investment strategy, production strategy and marketing strategy of Opioids Drug industry.
Data Source
1. Primary sources
◇ Main methods: sampling survey, telephone interview, field survey, in-depth interview, mystery customers, etc.
◇ Main research objects: industry companies, channel providers, companies from upstream & downstream, business (Sales) personnel, users, experts, scholars, third-party Market Research Institutions, etc.
2. Secondary sources
◇ Industry public information;
◇ Companies’ periodical statements;
◇ Statistics, customs, research center, industry association, industry & commerce, tax and other official data;
◇ Journal databases, libraries, scientific research institutions, colleges and universities literature;
◇ The opinions of senior experts in the industry;
Research Report Preparation Process & After-sale Service
1: Set up the research team:
Preliminary seminar, interpret customer needs, develop project implementation plan;
2: Secondary sources collection:
Database retrieval, literature retrieval, official data collection, enterprise reports, industry public information;
3: Primary sources collection:
Sampling survey, telephone interview, field survey, in-depth interview;
4: Report formation:
Sorting, evaluation and selection of materials and data, writing research report and completing the first draft; verifying data, supplementing content and further checking omissions and making up for deficiencies and perfecting the report;
5: After-sale service:
Free supplementary content or data update for 6 months.
Based on the type of product, the global Opioids Drug market segmented into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Others
Based on the end-use, the global Opioids Drug market classified into
Pain Relief
Anesthesia
Others
Based on geography, the global Opioids Drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Russia, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of South America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm